Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Current status on marine products with reversal effect on cancer multidrug resistance.

Abraham I, El Sayed K, Chen ZS, Guo H.

Mar Drugs. 2012 Oct;10(10):2312-21. doi: 10.3390/md10102312. Epub 2012 Oct 19. Review.

2.
3.

Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.

Huang XC, Sun YL, Salim AA, Chen ZS, Capon RJ.

Biochem Pharmacol. 2013 May 1;85(9):1257-68. doi: 10.1016/j.bcp.2013.02.005. Epub 2013 Feb 13.

PMID:
23415901
4.

Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.

Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y, Dai CL, Shi Z, Chen X, Fu L, Ambudkar SV, El Sayed K, Chen ZS.

Biochem Pharmacol. 2010 Nov 15;80(10):1497-506. doi: 10.1016/j.bcp.2010.08.001. Epub 2010 Aug 7.

5.

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

Pérez-Tomás R.

Curr Med Chem. 2006;13(16):1859-76. Review.

PMID:
16842198
6.

Overcoming multidrug resistance in human cancer cells by natural compounds.

Nabekura T.

Toxins (Basel). 2010 Jun;2(6):1207-24. doi: 10.3390/toxins2061207. Epub 2010 May 28. Review.

7.

Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.

Sun YL, Kathawala RJ, Singh S, Zheng K, Talele TT, Jiang WQ, Chen ZS.

Anticancer Drugs. 2012 Sep;23(8):865-73. doi: 10.1097/CAD.0b013e328354a196.

PMID:
22614107
8.

Transporter-mediated multidrug resistance and its modulation by Chinese medicines and other herbal products.

Wang Z, Ravula R, Cao M, Chow M, Huang Y.

Curr Drug Discov Technol. 2010 Mar;7(1):54-66. Review.

PMID:
20156136
9.
10.
11.

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

Ahmed-Belkacem A, Pozza A, Macalou S, Pérez-Victoria JM, Boumendjel A, Di Pietro A.

Anticancer Drugs. 2006 Mar;17(3):239-43. Review.

PMID:
16520651
12.

Curcumin as chemosensitizer.

Limtrakul P.

Adv Exp Med Biol. 2007;595:269-300. Review.

PMID:
17569216
13.

Relevance of multidrug resistance in the age of targeted therapy.

Türk D, Szakács G.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):246-52. Review.

PMID:
19333870
14.

Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.

Goler-Baron V, Assaraf YG.

PLoS One. 2012;7(4):e35487. doi: 10.1371/journal.pone.0035487. Epub 2012 Apr 18.

15.

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW.

Cancer Lett. 2009 Jun 28;279(1):74-83. doi: 10.1016/j.canlet.2009.01.027. Epub 2009 Feb 18.

PMID:
19232821
16.

UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporter.

Qiao D, Tang S, Aslam S, Ahmad M, To KK, Wang F, Huang Z, Cai J, Fu L.

Am J Cancer Res. 2014 Mar 1;4(2):148-60. eCollection 2014.

17.

ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.

Daood M, Tsai C, Ahdab-Barmada M, Watchko JF.

Neuropediatrics. 2008 Aug;39(4):211-8. doi: 10.1055/s-0028-1103272. Epub 2009 Jan 22.

18.

Multidrug resistance: molecular mechanisms and clinical relevance.

Ling V.

Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8. Review.

PMID:
9272126
19.
20.

Reversal of multidrug resitance by natural substances from plants.

Molnár J, Engi H, Hohmann J, Molnár P, Deli J, Wesolowska O, Michalak K, Wang Q.

Curr Top Med Chem. 2010;10(17):1757-68. Review.

PMID:
20645919
Items per page

Supplemental Content

Write to the Help Desk